Outcomes after first-line therapy for immune/immune or immune/VEGF combinations

Jackson-Spence, F; Jovaisaite, A; Grant, M; Liu, WK; Butters, T; Powles, T; Szabados, B

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (6):